| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +29% |
| 3Y CAGR | +3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +139% |
| 3Y CAGR | +4% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,802.60 -8.20 (0.29%) | 21,361.19 | 31.51 | 5.96 | ||
PfizerPFIZER | ₹4,573.50 -36.20 (0.79%) | 21,107.32 | 28.71 | 5.02 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,948.00 +4.00 (0.06%) | 17,327.00 | 102.15 | 19.85 | ||
Natco PharmaNATCOPHARM | ₹832.95 +4.30 (0.52%) | 14,848.21 | 12.97 | 1.61 |